Crosspoint Capital Strategies’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-8,239
Closed -$780K – 43
2017
Q4
$780K Sell
8,239
-705
-8% -$73.7K 0.65% 31
2017
Q3
$1.04M Hold
8,944
– – 0.81% 35
2017
Q2
$1.13M Hold
8,944
– – 0.98% 33
2017
Q1
$1.2M Sell
8,944
-392
-4% -$49.9K 1% 25
2016
Q4
$936K Sell
9,336
-565
-6% -$55.1K 0.83% 33
2016
Q3
$934K Hold
9,901
– – 1.26% 19
2016
Q2
$792K Sell
9,901
-10
-0.1% -$776 0.81% 29
2016
Q1
$718K Buy
+9,911
New +$739K 0.68% 35
2015
Q4
– Sell
-10,225
Closed -$1.13M – 1094
2015
Q3
$1.13M Sell
10,225
-14,251
-58% -$1.6M 1.31% 12
2015
Q2
$2.55M Buy
24,476
+10,676
+77% +$1.11M 0.72% 36
2015
Q1
$1.26M Sell
13,800
-438
-3% -$36.2K 0.61% 48
2014
Q4
$1.04M Buy
+14,238
New +$930K 0.36% 83
2014
Q2
– Sell
-145
Closed -$8K – 569
2014
Q1
$8K Sell
145
-91,001
-100% -$5.65M ﹤0.01% 499
2013
Q4
$6.06M Buy
+91,146
New +$3.97M 2.02% 14

Other funds holding INCY

Crosspoint Capital Strategies's INCY Position: Q1 2018 in Review

Crosspoint Capital Strategies sold out of Incyte (INCY) in Q1 2018, closing a stake of 8,239 shares — an estimated $780K sold.

Crosspoint Capital Strategies first reported a position in INCY in Q4 2013 and held it in 14 quarters. The position peaked at $6.06M in Q4 2013. 500 funds tracked by Wall St. Rank hold INCY as of Q1 2018.

  • Crosspoint Capital Strategies reported no remaining Incyte position as of Q1 2018 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 8,239 Incyte shares in Q1 2018, an estimated $780K.
  • Crosspoint Capital Strategies first reported a position in Incyte in Q4 2013 and held it in 14 quarters.
  • Crosspoint Capital Strategies's Incyte position peaked at $6.06M in Q4 2013.
  • 500 funds tracked by Wall St. Rank held Incyte as of Q1 2018.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2018, filed 14 May 2018.